Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma
Clinical trial NCT07564570 · RECRUITING
Trial details
- NCT number
- NCT07564570
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-14
- Primary completion
- 2027-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.